S 775 · 118th Congress · Health

Increasing Transparency in Generic Drug Applications Act

Introduced 2023-03-14· Sponsored by Sen. Hassan, Margaret Wood [D-NH]· Senate

Bill Progress

✓
Introduced
2
Committee
3
Senate Vote
4
House
5
Enacted
Latest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2023-03-14)

Plain Language Summary

[AI summary unavailable — showing source text] Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration (FDA) to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why). The FDA must also update or publish guidance on how it makes such determinations.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (3)

1 Democrat2 Republicans
Sen. Paul, Rand [R-KY]KY
Sen. Braun, Mike [R-IN]IN
Sen. Hickenlooper, John W. [D-CO]CO